key: cord-0956489-md8mxgrb
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: mRNA COVID-19 Vaccination and Myocarditis
date: 2022-01-31
journal: Pediatr Emerg Care
DOI: 10.1097/pec.0000000000002644
sha: c51a9872dabfb50e6ef01d768dcbb21675b7b80c
doc_id: 956489
cord_uid: md8mxgrb

nan

To the Editors: W e would like to share ideas on "Myocarditis following mRNA COVID-19 vaccine." 1 Visclosky et al 1 concluded that "Pointof-care ultrasound may be a tool used to rapidly diagnose or risk stratify patients with potential post-COVID-19 vaccine myocarditis." We agree that point-of-care ultrasound is a useful diagnostic tool. However, the interpretation usually requires an experienced practitioner and a tool that might not readily available. In our setting, no pointof-care ultrasound is available in primary hospital. For diagnostic management, electrocardiography and cardiac enzyme are still required. In the present case, the patient is likely to have myocarditis. However, it cannot definitively mention that it is due to COVID-19 vaccination. For myocarditis in a COVID-19 vaccine recipient, it might be a coincidence relating to other cause. In case that it is induced by immunopathological process, there should be evidence from abnormal immunological parameter. For another possible pathogenesis, a hyperviscosity-induced cardiac problem, an abnormal blood viscosity should be detected. 2,3

Private Academic Consultant Bangkok, Thailand rujittika@ggmail.com

Pune, India

Myocarditis following mRNA COVID-19 vaccine

Response to case report on myocarditis and pericarditis after COVID-19 vaccination

Acute myocardial injury following COVID-19 vaccination

Disclosure: The authors declare no conflict of interest.